CLINICAL_TRIALS
trial_result
· 2009-03-16
Clinical Trial Update: APIDRA Registration Study [Phase 4]
Summary
Phase 4 registration study of APIDRA (insulin glulisine) for Type 1 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 1 | Phase 4 | Status: COMPLETED